University of Regensburg

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1962-01-01

Employees: 1K

Market Cap: -

Website: http://www.uni-regensburg.de

Clinical Trials

Algorithm of Muscle Function Tests to Detect Residual Neuromuscular Blockade.

Not Applicable

Completed

Conditions: Postoperative Residual Curarization

Interventions: Device: Acceleromyography

First Posted Date: 2017-07-17

Last Posted Date: 2017-07-17

Lead Sponsor: University of Regensburg

Target Recruit Count: 265

Registration Number: NCT03219138

Locations: 🇩🇪
6Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Campus Kiel,, Kiel, Germany
🇩🇪
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster, Münster, Germany
🇩🇪
Klinik für Anaesthesiologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany

and more 2 locations

Seroma Prevention After Body Contouring Procedures

Not Applicable

Conditions: Abdominoplasty
Complication of Surgical Procedure
Seroma

Interventions: Procedure: Variable drain usage

First Posted Date: 2017-06-19

Last Posted Date: 2019-05-03

Lead Sponsor: University of Regensburg

Target Recruit Count: 100

Registration Number: NCT03190876

Locations: 🇩🇪
Department of Plastic Surgery, University Hospital of Regensburg, Regensburg, Bayern, Germany

Perioperative Management of DIEP Flaps

Not Applicable

Conditions: Mammaplasty
Microsurgery
Free Tissue Flaps

Interventions: Drug: Crystalloid Solutions
Drug: Catecholamines

First Posted Date: 2017-04-18

Last Posted Date: 2017-04-18

Lead Sponsor: University of Regensburg

Target Recruit Count: 100

Registration Number: NCT03118024

Locations: 🇩🇪
University hospital of Regensburg, Regensburg, Germany

Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia

Not Applicable

Completed

Conditions: Fear of Flying

Interventions: Behavioral: Diaphragmatic breathing
Behavioral: Virtual Reality Exposure Therapy

First Posted Date: 2016-12-13

Last Posted Date: 2016-12-13

Lead Sponsor: University of Regensburg

Target Recruit Count: 30

Registration Number: NCT02990208

EMDR in Spider Phobia: Work Mechanisms and Treatment Outcome

Not Applicable

Completed

Conditions: Spider Phobia

Interventions: Behavioral: Eye Movement Desensitization and Reprocessing Therapy
Behavioral: Virtual Reality Exposure Therapy

First Posted Date: 2016-11-28

Last Posted Date: 2016-11-28

Lead Sponsor: University of Regensburg

Target Recruit Count: 53

Registration Number: NCT02973919

Immune Monitoring of Hepatitis C Under DAA Therapy

Conditions: Hepatitis C

First Posted Date: 2016-09-19

Last Posted Date: 2016-09-21

Lead Sponsor: University of Regensburg

Target Recruit Count: 100

Registration Number: NCT02904603

Locations: 🇩🇪
University of Regensburg, Regensburg, Germany

Prospective, Multicenter HCCIS Evaluation Study

Conditions: Hepatocellular Carcinoma

Interventions: Other: Overall survival

First Posted Date: 2016-03-24

Last Posted Date: 2016-03-24

Lead Sponsor: University of Regensburg

Target Recruit Count: 200

Registration Number: NCT02718235

Influence of Treatment Duration and Stimulation Frequency on rTMS in Chronic Tinnitus

Not Applicable

Completed

Conditions: Chronic Tinnitus

Interventions: Other: high-frequency multisite two weeks
Other: high-frequency multisite four weeks
Other: standard multisite two weeks
Other: standard multisite four weeks

First Posted Date: 2016-01-12

Last Posted Date: 2018-06-18

Lead Sponsor: University of Regensburg

Target Recruit Count: 90

Registration Number: NCT02653547

Locations: 🇩🇪
University of Regensburg- Dept of Psychiatry, Regensburg, Germany

Daily Bitemporal Low-frequency Transcranial Random Noise Stimulation in Tinnitus (tRNS2-tin)

Not Applicable

Recruiting

Conditions: Chronic Tinnitus

Interventions: Device: lf-tRNS

First Posted Date: 2015-11-26

Last Posted Date: 2022-12-09

Lead Sponsor: University of Regensburg

Target Recruit Count: 30

Registration Number: NCT02615600

Locations: 🇩🇪
University of Regensburg - Deptartment of Psychiatry, Regensburg, Germany

Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

Phase 2

Completed

Conditions: Pineoblastoma

Interventions: Drug: Temozolomide
Drug: Irinotecan
Drug: Dasatinib
Drug: Rapamycin

First Posted Date: 2015-11-04

Last Posted Date: 2021-08-05

Lead Sponsor: University of Regensburg

Target Recruit Count: 4

Registration Number: NCT02596828

Locations: 🇩🇪
University Hospital of Regensburg, Regensburg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy